AMRZ

Amrize Ltd

Stock NYSE – Stock Market Prices, News & Analysis

Company specialized in the development and sale of digital financial solutions aimed at improving asset management and banking operations.

$ 57.55
1.98 %

Amrize Ltd

$ 57.55
1.98 %
AMRZ

Company specialized in the development and sale of digital financial solutions aimed at improving asset management and banking operations.

Price history of Amrize Ltd
Price history of Amrize Ltd

Performance & Momentum

6 Months 18.68 %
1 Year 11.94 %
3 Years 11.94 %
5 Years 18.75 %

Strategic Analysis

Amrize Ltd • 2026

Amrize positions itself as an innovative player in the fintech sector by offering advanced digital solutions for asset management and banking operations, aimed at improving the performance and efficiency of financial institutions. Its business model is based on technological integration and expansion through targeted acquisitions, consolidating its global presence and strengthening its portfolio of solutions.

Strengths
  • Recognized expertise in financial technology and digital innovation in asset management
  • Diversified portfolio of digital solutions enhancing client value added
  • Demonstrated ability to accelerate growth through strategic acquisitions
Weaknesses
  • High R&D investment requirements to maintain its technological edge
  • Exposure to intense competition in the global fintech market
Momentum

The stock’s momentum is positive, supported by robust growth dynamics and a recent market re-rating, notably driven by a strategic acquisition praised by analysts. This news strengthens confidence in the medium-term potential, with expectations of both organic and external expansion, steering the strategy toward consolidating its technological and geographic position.

Similar stocks to Amrize Ltd

Recent News

Amrize Ltd

illustration
Oppenheimer Raises Amrize Price Target to $70 After Acquisition
2 months ago

Amrize Ltd (NYSE: AMRZ) confirmed its positive momentum by acquiring PB Materials, a leading Texas-based aggregate materials company, bolstering its position in a rapidly growing market. Additionally, Q4 2025 results exceeded expectations with EBITDA reaching $779 million, prompting Oppenheimer to raise its price target to $70 while maintaining an 'Outperform' rating. These developments highlight Amrize's financial strength and growth strategy, supporting a higher valuation for its stock.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone